Macquarie Group
PRVA icon

Macquarie Group’s Privia Health PRVA Stock Holding History

Macquarie Group’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-92,806
Closed -$2.31M – 1339
2025
Q3 		$2.31M Sell
92,806
-1,826
-2% -$39.3K ﹤0.01% 1140
2025
Q2 		$2.18M Sell
94,632
-1,151
-1% -$26.6K ﹤0.01% 1197
2025
Q1 		$2.15M Sell
95,783
-2,214
-2% -$51.4K ﹤0.01% 1195
2024
Q4 		$1.92M Sell
97,997
-1,264
-1% -$25K ﹤0.01% 1209
2024
Q3 		$1.81M Buy
99,261
+267
+0.3% +$5.09K ﹤0.01% 1263
2024
Q2 		$1.72M Buy
98,994
+9,270
+10% +$164K ﹤0.01% 1273
2024
Q1 		$1.76M Buy
89,724
+13,650
+18% +$288K ﹤0.01% 1261
2023
Q4 		$1.75M Buy
76,074
+3,839
+5% +$85.9K ﹤0.01% 1259
2023
Q3 		$1.66M Buy
72,235
+13,701
+23% +$348K ﹤0.01% 1221
2023
Q2 		$1.53M Sell
58,534
-1,095,849
-95% -$28.9M ﹤0.01% 1261
2023
Q1 		$31.9M Sell
1,154,383
-167,334
-13% -$4.42M 0.04% 558
2022
Q4 		$30M Buy
1,321,717
+90,658
+7% +$2.52M 0.04% 606
2022
Q3 		$42M Buy
1,231,059
+431,706
+54% +$16M 0.05% 482
2022
Q2 		$23.3M Buy
799,353
+724,449
+967% +$18.4M 0.03% 676
2022
Q1 		$2M Buy
74,904
+2,385
+3% +$56.3K ﹤0.01% 1371
2021
Q4 		$1.88M Buy
72,519
+1,756
+2% +$43.8K ﹤0.01% 1391
2021
Q3 		$1.67M Buy
70,763
+17,155
+32% +$599K ﹤0.01% 1439
2021
Q2 		$2.38M Buy
+53,608
New +$1.98M ﹤0.01% 1362

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Macquarie Group's PRVA Position: Q4 2025 in Review

Macquarie Group sold out of Privia Health (PRVA) in Q4 2025, closing a stake of 92,806 shares — an estimated $2.31M sold.

Macquarie Group first reported a position in PRVA in Q2 2021 and held it in 18 quarters. The position peaked at $42M in Q3 2022. 276 funds tracked by Wall St. Rank hold PRVA as of Q4 2025.

  • Macquarie Group reported no remaining Privia Health position as of Q4 2025 after selling out during the quarter.
  • Macquarie Group sold 92,806 Privia Health shares in Q4 2025, an estimated $2.31M.
  • Macquarie Group first reported a position in Privia Health in Q2 2021 and held it in 18 quarters.
  • Macquarie Group's Privia Health position peaked at $42M in Q3 2022.
  • 276 funds tracked by Wall St. Rank held Privia Health as of Q4 2025.

Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.